Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Net Income (Quarterly): -52.52M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -52.52M |
| June 30, 2024 | -55.33M |
| March 31, 2024 | -45.76M |
| December 31, 2023 | -65.64M |
| September 30, 2023 | -50.71M |
| June 30, 2023 | -42.38M |
| March 31, 2023 | -39.40M |
| Date | Value |
|---|---|
| December 31, 2022 | -39.28M |
| September 30, 2022 | -29.35M |
| June 30, 2022 | -29.35M |
| March 31, 2022 | -23.84M |
| December 31, 2021 | -62.91M |
| September 30, 2021 | -16.41M |
| December 31, 2019 | -2.529M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-65.64M
Minimum
Dec 2023
-2.529M
Maximum
Dec 2019
-39.67M
Average
-40.89M
Median
Net Income (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 1.211B |
| Molecular Templates Inc | -8.097M |
| CEL-SCI Corp | -6.857M |
| AIM ImmunoTech Inc | -1.836M |
| IGC Pharma Inc | -2.378M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.209M |
| Total Expenses (Quarterly) | 54.44M |
| EPS Diluted (Quarterly) | -0.44 |
| Enterprise Value | 263.21M |
| Profit Margin (Quarterly) | -25.13K% |
| Earnings Yield | -61.58% |